Development asset linked to Innovent Biologics in public FDA and regional records.
pharma · Hypertension
Innovent Biologics
Innovent Biologics (Suzhou) Co.
Innovent Biologics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Suzhou, CN HQ
2011 Founded
850 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Suzhou, CN
- Founded
- 2011
- Employees
- 850
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Innovent Biologics pipeline
Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Innovent Biologics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Innovent Biologics in public FDA and regional records.
-
Development asset linked to Innovent Biologics in public FDA and regional records.